Alnylam Pharmaceuticals, Inc.ALNYNASDAQ
Loading
Current Ratio Over TimeCompressed
Percentile Rank14
3Y CAGR-7.6%
5Y CAGR-9.2%
Year-over-Year Change
Current ratio (current assets / current liabilities)
3Y CAGR
-7.6%/yr
vs -14.9%/yr prior
5Y CAGR
-9.2%/yr
Consistent
Acceleration
+7.3pp
Accelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
8 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 2.76 | -0.6% |
| 2024 | 2.78 | -9.9% |
| 2023 | 3.08 | -12.1% |
| 2022 | 3.51 | -13.2% |
| 2021 | 4.04 | -9.6% |
| 2020 | 4.47 | -8.2% |
| 2019 | 4.87 | -27.3% |
| 2018 | 6.69 | -45.3% |
| 2017 | 12.23 | +139.8% |
| 2016 | 5.10 | - |